Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies
Clinical trial NCT03126110 · COMPLETED
Trial details
- NCT number
- NCT03126110
- Sponsor
- Incyte Biosciences International Sàrl
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-25
- Primary completion
- 2021-11-09
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.